The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

TEVA FINANCIAL STATEMENTS

Teva Pharma Industries Ltd ADR — balance sheet, income statement and cash flow trends

TEVATeva Pharma Industries Ltd ADR

🇺🇸 USA · US · Healthcare · Drug Manufacturers - Specialty & Generic

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
010 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue17.3 B $Gross Profit9.1 B $ · 52%Operating Income2 B $ · 11%Pre-tax Income720 M $ · 4%Net Income to Owners706 M $ · 4%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue17.3 B $+4.1%
Gross Profit9.1 B $+10.2%
Operating Income2 B $+121.8%
EBITDA2.6 B $-12.9%
Net Income to Owners706 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
020 B40 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets39.9 B
  • Equity7.8 B $19%
  • Current Liabilities15.6 B $39%
  • Long-term Liabilities16.5 B $41%

Key Figures

YoY change
Total Assets39.9 B $-0.7%
Total Liabilities32.1 B $-3.6%
Total Equity7.8 B $+13.6%
Cash & ST Investments3.7 B $+69.1%
Total Debt16.9 B $-3.7%
Net Debt13.2 B $-14.0%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
01 B202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
01 B2 B1.9 B $Operating38 M $Investing-401 M $Financing1.5 B $Net Change

Key Figures

YoY change
Operating Cash Flow1.9 B $+36.5%
Capital Expenditures550 M $+10.0%
Free Cash Flow1.3 B $+51.5%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on TEVA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 23, 26. This content is for informational purposes only and is not investment advice.